US Stock MarketDetailed Quotes

INTA Intapp

Watchlist
  • 57.210
  • -3.900-6.38%
Close Mar 10 16:00 ET
  • 57.210
  • 0.0000.00%
Pre 06:55 ET
4.54BMarket Cap-197.28P/E (TTM)

Intapp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Intapp Q2 2025 Earnings Date

Currency：USDFeb 4, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
121.14M
121.21M
+65.59K
Beat Est.
+16.56%
+16.62%
+0.05%
EPS
-0.14
-0.13
+0.01
Beat Est.
-11.16%
0.00%
+9.97%
Analyst Rating
Buy

Mar 10, 2025

Intapp Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 132.073M--
--2025/Q3-- / 128.841M--
Feb 4, 20252025/Q2121.209M / 121.143M--
Nov 4, 20242025/Q1118.805M / 117.810M--
Aug 13, 20242024/Q4114.376M / 111.616M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 132.073M--
--2025/Q3-- / 128.841M--
Feb 4, 20252025/Q2121.209M / 121.143M--
Nov 4, 20242025/Q1118.805M / 117.810M--
Aug 13, 20242024/Q4114.376M / 111.616M--

Unlock Free Earnings Estimates

Intapp Earnings Reports

  • Intapp | 8-K: Intapp Announces Second Quarter Fiscal Year 2025 Financial Results

    Feb 4 07:53 ET

  • Intapp | 10-Q: Q2 2025 Earnings Report

    Feb 4 07:45 ET

  • Intapp | 10-Q: Q1 2025 Earnings Report

    Nov 7, 2024 16:14 ET

  • Intapp | 8-K: Intapp Announces First Quarter Fiscal Year 2025 Financial Results

    Nov 4, 2024 16:20 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Lantheus
    LNTH
    +3.45%
    Collegium Pharmaceutical
    COLL
    +2.59%
    Constellation Brands
    STZ
    +1.73%
    Halozyme Therapeutics
    HALO
    +0.75%
    AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
    AIPUY
    0.00%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Mar 10, 2025

    Buy

    • Buy

      62.50%

    • Hold

      37.50%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme DeepSeek Beneficiaries
    DeepSeek Beneficiaries
    Intraday-5.14%